Form 4 for CRL Charles River Laboratories
Accepted 2023-05-15 00:00:00 ET · period of report 2023-05-12 · accession 0001127602-23-015525 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-15 | 2023-05-12 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $193.03 | -959 | 24.4K | -4% | -$185.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-12 | S | D | 9 | $194.07 | 24,371 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-12 | S | D | 950 | $193.02 | 24,380 | D | — | — |